Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Matinas BioPharma Inc.

    AMEX: MTNB · Real-Time Price · USD
    2.31
    0.66 (40.00%)
    At close: Aug 15, 2025, 3:59 PM
    2.42
    4.99%
    After-hours: Aug 15, 2025, 07:58 PM EDT

    Matinas BioPharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 7.28M 4.79M 6.83M 21.03M
    Short-Term Investments
    		 n/a 8.97M 21.93M 28.59M
    Long-Term Investments
    		 n/a n/a 200K n/a
    Other Long-Term Assets
    		 200K 200K -34.05M 200K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 741K 50K 5.77M 50K
    Total Current Assets
    		 8.03M 15.54M 34.53M 50.99M
    Property-Plant & Equipment
    		 2.16M 5.01M 5.73M 5.78M
    Goodwill & Intangibles
    		 2.26M 4.35M 4.35M 4.35M
    Total Long-Term Assets
    		 4.62M 9.56M 10.29M 10.33M
    Total Assets
    		 12.64M 25.1M 44.82M 61.33M
    Account Payables
    		 95K 514K 618K 937K
    Deferred Revenue
    		 n/a n/a 721K 932K
    Short-Term Debt
    		 766K n/a 569K n/a
    Other Current Liabilities
    		 292K 271K 825K 1.51M
    Total Current Liabilities
    		 2.67M 2.62M 4.29M 4.35M
    Long-Term Debt
    		 n/a n/a n/a 4.14B
    Other Long-Term Liabilities
    		 n/a n/a n/a -4.14B
    Total Long-Term Liabilities
    		 2.38M 3.24M 3.9M 4.48M
    Total Liabilities
    		 5.05M 5.86M 8.18M 8.83M
    Total Debt
    		 2.89M 3.56M 4.12M 4.7M
    Common Stock
    		 1K 22K 22K 21.63K
    Retained Earnings
    		 -199.82M -175.57M -152.63M -131.63M
    Comprehensive Income
    		 n/a -221K -824K -145.5K
    Shareholders Equity
    		 7.59M 19.25M 36.64M 52.49M
    Total Investments
    		 n/a 8.97M 21.93M 28.59M

    Add to Watchlist